Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.65 - $3.92 $75,063 - $111,037
28,326 New
28,326 $87,000
Q3 2023

Nov 22, 2023

SELL
$1.5 - $3.75 $42,201 - $105,502
-28,134 Reduced 64.61%
15,409 $29,000
Q2 2023

Aug 14, 2023

SELL
$2.21 - $4.43 $66,467 - $133,236
-30,076 Reduced 40.85%
43,543 $121,000
Q1 2023

May 15, 2023

BUY
$3.81 - $6.76 $54,162 - $96,100
14,216 Added 23.93%
73,619 $304,000
Q4 2022

Feb 14, 2023

BUY
$4.26 - $6.84 $253,056 - $406,316
59,403 New
59,403 $276,000
Q2 2022

Aug 15, 2022

BUY
$8.35 - $21.89 $542,507 - $1.42 Million
64,971 New
64,971 $679,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.